EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer-Reference-Cited by-同舟云学术

EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer

Published:2017-12-12 Issue:5 Volume:45 Page:824-845
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Poeppel Thorsten D.,Handkiewicz-Junak Daria,Andreeff Michael,Becherer Alexander,Bockisch Andreas,Fricke Eva,Geworski Lilli,Heinzel Alexander,Krause Bernd J.,Krause Thomas,Mitterhauser Markus,Sonnenschein Wilfried,Bodei Lisa,Delgado-Bolton Roberto C.,Gabriel Michael

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-017-3900-4/fulltext.html

Reference31 articles.

1. Shore ND. Radium-223 dichloride for metastatic castration-resistant prostate cancer: the urologist's perspective. Urology. 2015;85:717–24.

2. Bayer AG. Xofigo Summary of Product Characteristics (SmPC). 2016.

3. Heidenreich A, Bastian PJ, Bellmunt J, Bolla M, Joniau S, van der Kwast T, et al. EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol. 2014;65:467–79.

4. Coleman RE. Skeletal complications of malignancy. Cancer. 1997;80:1588–94.

5. Pandit-Taskar N, Larson SM, Carrasquillo JA. Bone-seeking radiopharmaceuticals for treatment of osseous metastases, part 1: alpha therapy with 223Ra-dichloride. J Nucl Med. 2014;55:268–74.

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developments in radionanotheranostic strategies for precision diagnosis and treatment of prostate cancer;EJNMMI Radiopharmacy and Chemistry;2024-08-24

2. Scalability study on [133La]LaCl3 production with a focus on potential clinical applications;EJNMMI Radiopharmacy and Chemistry;2024-08-15

3. Future Treatment Strategies for Cancer Patients Combining Targeted Alpha Therapy with Pillars of Cancer Treatment: External Beam Radiation Therapy, Checkpoint Inhibition Immunotherapy, Cytostatic Chemotherapy, and Brachytherapy;Pharmaceuticals;2024-08-05

4. Navigating through the coordination preferences of heavy alkaline earth metals: Laying the foundations for 223Ra- and 131/135mBa-based targeted alpha therapy and theranostics of cancer;Journal of Inorganic Biochemistry;2024-07

5. Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine;Seminars in Nuclear Medicine;2024-05